Passage Bio Is A Clinical Stage Genetic Medicines Company Based In Philadelphiapennsylvaniathe Company Is Dedicated To Developing Therapies For Patients With Central Nervous Systemcnsdiseasesparticularly Those With Limited Or No Approved Treatment Optionstheir Mission Is To Enhance The Lives Of Individuals With Neurodegenerative Diseases Through Innovative Gene Therapy Approaches The Company Specializes In One Time Gene Therapies For Rare Cns Disorderswith Several Candidates Currently In Phase 1 2 Clinical Trialsnotable Product Candidates Include Pbgm01Aimed At Treating Gm1 Gangliosidosisand Pbft02Which Targets Frontotemporal Dementiaamyotrophic Lateral Sclerosisand Alzheimerae S Diseasepassage Bio Collaborates With The University Of Pennsylvania S Gene Therapy Program To Advance Its Research And Development Efforts Passage Bio Operates A Manufacturing And Global Clinical Distribution Center In Hopewellnew Jerseythe Company Is Publicly Traded On The Nasdaq Under The Ticker Symbol Pasg And Employs Between 51 And 200 People In The Biotechnology Sector
No conferences found for this company.
| Company Name | Passage Bio Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
